<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2982">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04404608</url>
  </required_header>
  <id_info>
    <org_study_id>201920008.2</org_study_id>
    <nct_id>NCT04404608</nct_id>
  </id_info>
  <brief_title>Etiology of Lymphopenia in Covid19 Infection</brief_title>
  <official_title>Study of the Etiology of Lymphopenia in Covid19 Viral Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr Medhat Khafagy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study of the cause of lymphopenia in Covid19 viral infection will be done in 3 cohorts. First
      cohort will be patients asymptomatic or with mild symptoms. Second cohort will be patients
      with severe illness and admitted to ICU. Third cohort will be patients critically ill and on
      artificial ventilation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each cohort will include 30 patients. Complete blood count in all patients will be done daily
      in all patients. Bone marrow aspiration cytology will be done in some selected patients
      especially those with lymphopenia less than 1000 per cubic mm.

      Correlation of the degree of lymphopenia with the status of the patients will be done. Also
      correlation will be done about the relation of recovery of lymphopenia and status of the
      patients.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Death or recovery</measure>
    <time_frame>Up to 24 weeks</time_frame>
    <description>Follow up</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Lymphopenia</condition>
  <arm_group>
    <arm_group_label>Asymptomatic or mild symptoms patients patients</arm_group_label>
    <description>Patients with no or mild symptoms and need no respiratory support.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Severe symptoms patients</arm_group_label>
    <description>Patients who need admission to ICU because he needs oxygen by nasal canula and needs drugs whether azthromycin or remdesivir according to treatment protocol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Critically ill patients</arm_group_label>
    <description>Patients who need artificial ventilation because of many causes and may need plasma from convalescent patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Complete blood picture, bone marrow aspiration cytology</intervention_name>
    <description>none except the regular routine investigations in such cases</description>
    <arm_group_label>Asymptomatic or mild symptoms patients patients</arm_group_label>
    <arm_group_label>Critically ill patients</arm_group_label>
    <arm_group_label>Severe symptoms patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients admitted with the diagnosis off Covid19 viral infection of all ages and all
        ethnic backgrounds and agree about the study
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient admitted with the diagnosis of Covid19 viral infection

        Exclusion Criteria:

          -  Any patient who died within one day of admission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 23, 2020</study_first_submitted>
  <study_first_submitted_qc>May 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 27, 2020</study_first_posted>
  <last_update_submitted>May 26, 2020</last_update_submitted>
  <last_update_submitted_qc>May 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Dr Medhat Khafagy</investigator_full_name>
    <investigator_title>professor of surgical oncology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphopenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

